BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J, Zhu H, Dai Z, Wang D, Tang D. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered 2021;12:720-35. [PMID: 33618627 DOI: 10.1080/21655979.2021.1889109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Niu Y, Wang Z, Xu X, Li Y, Ma L, Wang J, Yu Y. Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cells. Cell Death Dis 2021;12:889. [PMID: 34588426 DOI: 10.1038/s41419-021-04164-y] [Reference Citation Analysis]
2 Ascenção K, Szabo C. Emerging roles of cystathionine β-synthase in various forms of cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102331] [Reference Citation Analysis]
3 Fu L, Shi Z, Chen B. Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells. Bioengineered 2022;13:12847-62. [PMID: 35611845 DOI: 10.1080/21655979.2022.2076482] [Reference Citation Analysis]
4 Zhang Z, Tang D. The huge clinical potential of microbiota in the treatment of pancreatic cancer: The next frontier. Biochim Biophys Acta Rev Cancer 2022;:188733. [PMID: 35483491 DOI: 10.1016/j.bbcan.2022.188733] [Reference Citation Analysis]
5 Guo Q, Lin H, Chen P, Tan S, Wen Z, Lin L, He J, Wen J, Lu S. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules. Bioengineered 2021;12:11885-97. [PMID: 34923901 DOI: 10.1080/21655979.2021.1999374] [Reference Citation Analysis]
6 Guz M, Jeleniewicz W, Malm A, Korona-Glowniak I. A Crosstalk between Diet, Microbiome and microRNA in Epigenetic Regulation of Colorectal Cancer. Nutrients 2021;13:2428. [PMID: 34371938 DOI: 10.3390/nu13072428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer 2022. [PMID: 35102280 DOI: 10.1038/s41568-021-00435-0] [Reference Citation Analysis]
8 Chen T, Ding R, Chen X, Lu Y, Shi J, Lü Y, Tang B, Zhang W, Ye C, Yuan M, Yang Z. Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study. Bioengineered 2021;12:8233-46. [PMID: 34592890 DOI: 10.1080/21655979.2021.1982273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tan X, Mao L, Huang C, Yang W, Guo J, Chen Z, Chen Z. Comprehensive analysis of lncRNA-miRNA-mRNA regulatory networks for microbiota-mediated colorectal cancer associated with immune cell infiltration. Bioengineered 2021;12:3410-25. [PMID: 34227920 DOI: 10.1080/21655979.2021.1940614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bennedsen ALB, Furbo S, Bjarnsholt T, Raskov H, Gögenur I, Kvich L. The gut microbiota can orchestrate the signaling pathways in colorectal cancer. APMIS 2022;130:121-39. [PMID: 35007370 DOI: 10.1111/apm.13206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]